🇺🇸 Oral Risperidone in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 3
Most-reported reactions
- Antipsychotic Drug Level Below Therapeutic — 1 report (33.33%)
- Hallucination, Auditory — 1 report (33.33%)
- Intentional Product Misuse — 1 report (33.33%)
Other Psychiatry/Neurology approved in United States
Frequently asked questions
Is Oral Risperidone approved in United States?
Oral Risperidone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Oral Risperidone in United States?
Zogenix, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.